Heparin-induced thrombocytopenia (HIT) can be a serious complication of unfractionated heparin therapy. There are two types of HIT: Type I HIT: This form is non-immune mediated.

A new report suggests that one episode of heparin-induced thrombocytopenia need not rule out the future use of heparin, at least in the context of cardiac procedures. A simple screen for the ...

Heparin-induced thrombocytopenia, a serious immune-mediated drug reaction, can occur as an isolated incident (isolated HIT) or with acute thrombosis sometimes referred to as HIT and associated ...

Heparin-induced thrombocytopenia developed in a 59-year-old man while he was receiving heparin for symptomatic atherothrombosis involving both superficial femoral arteries ().The diagnosis was ...

Heparin-induced thrombocytopenia (HIT) ... Heparin: An anticoagulant medication used to prevent blood clots, which can, in some cases, induce immune-mediated adverse effects leading to HIT.

Heparin-Induced Thrombocytopenia (HIT) is a life-threatening complication following heparin exposure. The webinar presentation will discuss the pathogenesis, incidence, clinical and laboratory ...

Introduction. Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction mediated by platelet-activating immunoglobulin G (IgG) antibodies that target complexes of platelet factor 4 (PF4) ...

Heparin is widely used as an anticoagulant, but evokes in some patients a potentially life-threatening condition called HIT. Clinical scientists at Ludwig-Maximilians-Universitaet (LMU) in Munich ...

To the Editor: The article on temporal aspects of heparin-induced thrombocytopenia (April 26 issue)1 lacks some information that would be helpful. In particular, there is no mention of the type of ...

In the study, the seven patients with HIT had antibodies to PF4/heparin and the diagnosis was confirmed using the heparin-induced platelet aggregation test. Bikdeli said the standard criteria for ...

The HIT market is projected to be around USD 128 million in 2023 across the 7MM, with the US holding the largest share of diagnosed cases at 51%. HIT, a severe immune reaction following heparin ...

Heparin-Induced Thrombocytopenia (HIT) Treatment market players – Pfizer Inc., Alleviare Life Sciences Pvt. Ltd., ANDOZ, GlaxoSmithKline Plc., Eagle Pharmaceuticals Inc, among others represent the ...